Recent Event


October 17, 2017

Esperion Investor Conference

Speaker: Jane F. Barlow

Real Endpoints LLC

Implications for bempedoic acid?

• Creating and delivering on payer expectations is key

• Payers will welcome an option that is lower cost than PCSK9 inhibitors

• There remains a sizeable number of patients that can’t get to goal with statins and ezetimibe

• Payers’ feedback on the profiles of the combination and bempedoic acid:

‒ On-going cardiovascular outcomes trials – potential limitation

‒ New mechanism of action – positive

‒ LDL-C lowering ability and safety profile – positive

‒ Oral route of administration; less complexity – positive

‒ Combination drug (bempedoic acid + ezetimibe) – positive

view event >

Recent Events

August 20, 2018 - August 24, 2018

Grand Hyatt, Washington, DC

Speaker: Roger Longman

Real Endpoints LLC

Cambridge Healthtech Institute’s Seventh Annual, Coverage and Reimbursement for Advanced Diagnostics – Latest Developments in the Dx Reimbursement Landscape. Ammar Qadan, Vice President, Global Market Access, Illumina and Roger Longman, CEO, RealEndpoints present: Addressing the Biggest Commercial Problem in Diagnostics

view event >

July 24, 2018 - July 25, 2018

Baltimore, MD

Panelist: Jane F. Barlow, MD, MPH, MBA

Real Endpoints LLC

To explore new models of payment and benefit designs for high-investment medications, the AMCP convened a stakeholder conference in Baltimore Maryland on July 24 and 25, 2018. Health care leaders representing health plans, integrated delivery systems, pharmacy benefit managers, employers, national professional associations, the federal government, and biopharmaceutical companies participated in the forum.

view event >

May 19, 2018 - May 23, 2018

Baltimore, MD

Attendee: Real Endpoints team

ISPOR is the leading global scientific and educational organization for health economics and outcomes research (HEOR) and its use in decision making to improve health. Our annual conference includes over 5,000 attendess from across the industry.

view event >

May 17, 2018 12:00pm ET

Roger Longman
Jane Barlow, MD

Real Endpoints LLC

We’ve seen an explosion of value-based deals: from 10 in 2015-2016 to 25 from 2017 to Q1 2018 (and we’re on pace for 30+ this year), according to the Real Endpoints database. But we’ve also had the time to see which deals from 2015-16 haven’t worked — and why. We will take a candid look at what’s worked and what hasn’t worked in value-based agreements — as well as preview the drugs coming to market in 2018 that could benefit from value-based agreements.

view event >

May 8, 2018 4:15pm ET

New York, NY

Panelist: Roger Longman

Real Endpoints LLC

Value & Pricing Redux – Does the Song Remain the Same?

view event >

April 29, 2018 - May 2, 2018

Table 10| The Palazzo| Las Vegas, NV

Speaker and Host: Roger Longman

Attendee: Real Endpoints Team

Asembia’s Annual Specialty Pharmacy Summit will return to Wynn & Encore Las Vegas from April 29 through May 2, 2018. The Summit welcomes thousands of industry executives and professionals. Agenda highlights include business workshops, educational seminars, exhibits, and live continuing education credits, along with numerous networking and social events.

view event >